nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—Bortezomib—hematologic cancer	0.378	1	CrCtD
Lacosamide—CA9—hematologic cancer	0.116	1	CbGaD
Lacosamide—Nateglinide—Bortezomib—hematologic cancer	0.0605	0.341	CrCrCtD
Lacosamide—Aspartame—Bortezomib—hematologic cancer	0.0574	0.324	CrCrCtD
Lacosamide—Phenacemide—Vorinostat—hematologic cancer	0.0458	0.258	CrCrCtD
Lacosamide—CA3—Imatinib—hematologic cancer	0.0429	0.191	CbGbCtD
Lacosamide—CA3—Nilotinib—hematologic cancer	0.039	0.174	CbGbCtD
Lacosamide—CA14—Imatinib—hematologic cancer	0.0178	0.0793	CbGbCtD
Lacosamide—CA6—Imatinib—hematologic cancer	0.0169	0.0753	CbGbCtD
Lacosamide—CA14—Nilotinib—hematologic cancer	0.0162	0.0721	CbGbCtD
Lacosamide—CA6—Nilotinib—hematologic cancer	0.0154	0.0685	CbGbCtD
Lacosamide—L-Phenylalanine—Melphalan—hematologic cancer	0.0135	0.076	CrCrCtD
Lacosamide—CA9—Imatinib—hematologic cancer	0.0126	0.0564	CbGbCtD
Lacosamide—CA1—Imatinib—hematologic cancer	0.0118	0.0527	CbGbCtD
Lacosamide—CA9—Nilotinib—hematologic cancer	0.0115	0.0512	CbGbCtD
Lacosamide—CA1—Nilotinib—hematologic cancer	0.0108	0.0479	CbGbCtD
Lacosamide—CA2—Imatinib—hematologic cancer	0.0102	0.0456	CbGbCtD
Lacosamide—CA4—Nilotinib—hematologic cancer	0.0101	0.045	CbGbCtD
Lacosamide—CA2—Nilotinib—hematologic cancer	0.00929	0.0414	CbGbCtD
Lacosamide—SCN10A—hematopoietic system—hematologic cancer	0.000551	0.0465	CbGeAlD
Lacosamide—CA3—bone marrow—hematologic cancer	0.000521	0.044	CbGeAlD
Lacosamide—CA5B—hematopoietic system—hematologic cancer	0.000516	0.0436	CbGeAlD
Lacosamide—CA3—lung—hematologic cancer	0.000472	0.0399	CbGeAlD
Lacosamide—CA1—hematopoietic system—hematologic cancer	0.000456	0.0385	CbGeAlD
Lacosamide—CA3—testis—hematologic cancer	0.000445	0.0376	CbGeAlD
Lacosamide—CA9—testis—hematologic cancer	0.000426	0.036	CbGeAlD
Lacosamide—SCN9A—lung—hematologic cancer	0.00042	0.0355	CbGeAlD
Lacosamide—SCN9A—testis—hematologic cancer	0.000396	0.0335	CbGeAlD
Lacosamide—CA5B—gonad—hematologic cancer	0.000393	0.0332	CbGeAlD
Lacosamide—SCN10A—blood—hematologic cancer	0.000365	0.0308	CbGeAlD
Lacosamide—CA5B—blood—hematologic cancer	0.000342	0.0289	CbGeAlD
Lacosamide—SCN3A—blood—hematologic cancer	0.000332	0.0281	CbGeAlD
Lacosamide—CA3—lymph node—hematologic cancer	0.000323	0.0273	CbGeAlD
Lacosamide—SCN3A—bone marrow—hematologic cancer	0.000322	0.0272	CbGeAlD
Lacosamide—SCN10A—lung—hematologic cancer	0.00032	0.027	CbGeAlD
Lacosamide—CA1—blood—hematologic cancer	0.000302	0.0255	CbGeAlD
Lacosamide—CA5B—lung—hematologic cancer	0.0003	0.0253	CbGeAlD
Lacosamide—CA2—hematopoietic system—hematologic cancer	0.000296	0.025	CbGeAlD
Lacosamide—CA1—bone marrow—hematologic cancer	0.000292	0.0247	CbGeAlD
Lacosamide—SCN3A—lung—hematologic cancer	0.000291	0.0246	CbGeAlD
Lacosamide—SCN9A—lymph node—hematologic cancer	0.000287	0.0243	CbGeAlD
Lacosamide—CA5B—testis—hematologic cancer	0.000283	0.0239	CbGeAlD
Lacosamide—SCN3A—testis—hematologic cancer	0.000275	0.0232	CbGeAlD
Lacosamide—CA1—lung—hematologic cancer	0.000265	0.0224	CbGeAlD
Lacosamide—CA4—blood—hematologic cancer	0.000236	0.0199	CbGeAlD
Lacosamide—CA4—bone marrow—hematologic cancer	0.000229	0.0193	CbGeAlD
Lacosamide—SCN10A—lymph node—hematologic cancer	0.000219	0.0185	CbGeAlD
Lacosamide—CA4—lung—hematologic cancer	0.000207	0.0175	CbGeAlD
Lacosamide—CA5B—lymph node—hematologic cancer	0.000205	0.0173	CbGeAlD
Lacosamide—SCN3A—lymph node—hematologic cancer	0.000199	0.0168	CbGeAlD
Lacosamide—CA2—blood—hematologic cancer	0.000196	0.0165	CbGeAlD
Lacosamide—CA4—testis—hematologic cancer	0.000195	0.0165	CbGeAlD
Lacosamide—CA2—bone marrow—hematologic cancer	0.000189	0.016	CbGeAlD
Lacosamide—CA1—lymph node—hematologic cancer	0.000181	0.0153	CbGeAlD
Lacosamide—CA2—lung—hematologic cancer	0.000172	0.0145	CbGeAlD
Lacosamide—CA2—testis—hematologic cancer	0.000162	0.0137	CbGeAlD
Lacosamide—CA4—lymph node—hematologic cancer	0.000142	0.012	CbGeAlD
Lacosamide—CA2—lymph node—hematologic cancer	0.000117	0.00991	CbGeAlD
Lacosamide—Tinnitus—Methotrexate—hematologic cancer	1.38e-05	0.000202	CcSEcCtD
Lacosamide—Hypoaesthesia—Epirubicin—hematologic cancer	1.38e-05	0.000202	CcSEcCtD
Lacosamide—Vomiting—Vincristine—hematologic cancer	1.38e-05	0.000202	CcSEcCtD
Lacosamide—Urticaria—Prednisolone—hematologic cancer	1.38e-05	0.000202	CcSEcCtD
Lacosamide—Asthenia—Cisplatin—hematologic cancer	1.38e-05	0.000202	CcSEcCtD
Lacosamide—Cardiac disorder—Methotrexate—hematologic cancer	1.38e-05	0.000201	CcSEcCtD
Lacosamide—Fatigue—Triamcinolone—hematologic cancer	1.38e-05	0.000201	CcSEcCtD
Lacosamide—Rash—Vincristine—hematologic cancer	1.37e-05	0.0002	CcSEcCtD
Lacosamide—Dermatitis—Vincristine—hematologic cancer	1.37e-05	0.0002	CcSEcCtD
Lacosamide—Connective tissue disorder—Epirubicin—hematologic cancer	1.37e-05	0.0002	CcSEcCtD
Lacosamide—Headache—Vincristine—hematologic cancer	1.36e-05	0.000199	CcSEcCtD
Lacosamide—Loss of consciousness—Prednisone—hematologic cancer	1.36e-05	0.000199	CcSEcCtD
Lacosamide—Hepatobiliary disease—Doxorubicin—hematologic cancer	1.35e-05	0.000198	CcSEcCtD
Lacosamide—Nausea—Carmustine—hematologic cancer	1.35e-05	0.000198	CcSEcCtD
Lacosamide—Vomiting—Irinotecan—hematologic cancer	1.35e-05	0.000197	CcSEcCtD
Lacosamide—Vomiting—Mitoxantrone—hematologic cancer	1.35e-05	0.000197	CcSEcCtD
Lacosamide—Immune system disorder—Methotrexate—hematologic cancer	1.34e-05	0.000196	CcSEcCtD
Lacosamide—Nausea—Alitretinoin—hematologic cancer	1.34e-05	0.000196	CcSEcCtD
Lacosamide—Agranulocytosis—Doxorubicin—hematologic cancer	1.34e-05	0.000195	CcSEcCtD
Lacosamide—Rash—Mitoxantrone—hematologic cancer	1.34e-05	0.000195	CcSEcCtD
Lacosamide—Rash—Irinotecan—hematologic cancer	1.34e-05	0.000195	CcSEcCtD
Lacosamide—Dermatitis—Irinotecan—hematologic cancer	1.33e-05	0.000195	CcSEcCtD
Lacosamide—Dermatitis—Mitoxantrone—hematologic cancer	1.33e-05	0.000195	CcSEcCtD
Lacosamide—Headache—Irinotecan—hematologic cancer	1.33e-05	0.000194	CcSEcCtD
Lacosamide—Headache—Mitoxantrone—hematologic cancer	1.33e-05	0.000194	CcSEcCtD
Lacosamide—Nausea—Ifosfamide—hematologic cancer	1.32e-05	0.000194	CcSEcCtD
Lacosamide—Feeling abnormal—Triamcinolone—hematologic cancer	1.32e-05	0.000192	CcSEcCtD
Lacosamide—Diarrhoea—Cisplatin—hematologic cancer	1.32e-05	0.000192	CcSEcCtD
Lacosamide—Erythema multiforme—Epirubicin—hematologic cancer	1.31e-05	0.000192	CcSEcCtD
Lacosamide—Vomiting—Gemcitabine—hematologic cancer	1.31e-05	0.000192	CcSEcCtD
Lacosamide—Insomnia—Dexamethasone—hematologic cancer	1.31e-05	0.000192	CcSEcCtD
Lacosamide—Insomnia—Betamethasone—hematologic cancer	1.31e-05	0.000192	CcSEcCtD
Lacosamide—Bradycardia—Doxorubicin—hematologic cancer	1.31e-05	0.000191	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.31e-05	0.000191	CcSEcCtD
Lacosamide—Paraesthesia—Dexamethasone—hematologic cancer	1.3e-05	0.00019	CcSEcCtD
Lacosamide—Paraesthesia—Betamethasone—hematologic cancer	1.3e-05	0.00019	CcSEcCtD
Lacosamide—Discomfort—Prednisone—hematologic cancer	1.3e-05	0.00019	CcSEcCtD
Lacosamide—Mental disorder—Methotrexate—hematologic cancer	1.3e-05	0.00019	CcSEcCtD
Lacosamide—Rash—Gemcitabine—hematologic cancer	1.3e-05	0.00019	CcSEcCtD
Lacosamide—Dermatitis—Gemcitabine—hematologic cancer	1.3e-05	0.00019	CcSEcCtD
Lacosamide—Eye disorder—Epirubicin—hematologic cancer	1.3e-05	0.00019	CcSEcCtD
Lacosamide—Hypersensitivity—Etoposide—hematologic cancer	1.3e-05	0.00019	CcSEcCtD
Lacosamide—Tinnitus—Epirubicin—hematologic cancer	1.3e-05	0.000189	CcSEcCtD
Lacosamide—Erythema—Methotrexate—hematologic cancer	1.29e-05	0.000189	CcSEcCtD
Lacosamide—Headache—Gemcitabine—hematologic cancer	1.29e-05	0.000189	CcSEcCtD
Lacosamide—Nausea—Vincristine—hematologic cancer	1.29e-05	0.000189	CcSEcCtD
Lacosamide—Cardiac disorder—Epirubicin—hematologic cancer	1.29e-05	0.000188	CcSEcCtD
Lacosamide—Hepatitis—Doxorubicin—hematologic cancer	1.29e-05	0.000188	CcSEcCtD
Lacosamide—Hypersensitivity—Prednisolone—hematologic cancer	1.28e-05	0.000187	CcSEcCtD
Lacosamide—Hypoaesthesia—Doxorubicin—hematologic cancer	1.28e-05	0.000187	CcSEcCtD
Lacosamide—Dyspepsia—Betamethasone—hematologic cancer	1.28e-05	0.000186	CcSEcCtD
Lacosamide—Dyspepsia—Dexamethasone—hematologic cancer	1.28e-05	0.000186	CcSEcCtD
Lacosamide—Urticaria—Triamcinolone—hematologic cancer	1.27e-05	0.000185	CcSEcCtD
Lacosamide—Asthenia—Etoposide—hematologic cancer	1.26e-05	0.000185	CcSEcCtD
Lacosamide—Connective tissue disorder—Doxorubicin—hematologic cancer	1.26e-05	0.000185	CcSEcCtD
Lacosamide—Body temperature increased—Triamcinolone—hematologic cancer	1.26e-05	0.000185	CcSEcCtD
Lacosamide—Nausea—Mitoxantrone—hematologic cancer	1.26e-05	0.000184	CcSEcCtD
Lacosamide—Nausea—Irinotecan—hematologic cancer	1.26e-05	0.000184	CcSEcCtD
Lacosamide—Immune system disorder—Epirubicin—hematologic cancer	1.26e-05	0.000183	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.25e-05	0.000183	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.25e-05	0.000183	CcSEcCtD
Lacosamide—Fatigue—Betamethasone—hematologic cancer	1.25e-05	0.000183	CcSEcCtD
Lacosamide—Fatigue—Dexamethasone—hematologic cancer	1.25e-05	0.000183	CcSEcCtD
Lacosamide—Pruritus—Etoposide—hematologic cancer	1.25e-05	0.000182	CcSEcCtD
Lacosamide—Shock—Prednisone—hematologic cancer	1.24e-05	0.000181	CcSEcCtD
Lacosamide—Nervous system disorder—Prednisone—hematologic cancer	1.24e-05	0.000181	CcSEcCtD
Lacosamide—Skin disorder—Prednisone—hematologic cancer	1.23e-05	0.000179	CcSEcCtD
Lacosamide—Nausea—Gemcitabine—hematologic cancer	1.23e-05	0.000179	CcSEcCtD
Lacosamide—Vomiting—Cisplatin—hematologic cancer	1.22e-05	0.000179	CcSEcCtD
Lacosamide—Hyperhidrosis—Prednisone—hematologic cancer	1.22e-05	0.000178	CcSEcCtD
Lacosamide—Vision blurred—Methotrexate—hematologic cancer	1.22e-05	0.000178	CcSEcCtD
Lacosamide—Mental disorder—Epirubicin—hematologic cancer	1.22e-05	0.000178	CcSEcCtD
Lacosamide—Erythema multiforme—Doxorubicin—hematologic cancer	1.22e-05	0.000178	CcSEcCtD
Lacosamide—Rash—Cisplatin—hematologic cancer	1.21e-05	0.000177	CcSEcCtD
Lacosamide—Dermatitis—Cisplatin—hematologic cancer	1.21e-05	0.000177	CcSEcCtD
Lacosamide—Erythema—Epirubicin—hematologic cancer	1.21e-05	0.000177	CcSEcCtD
Lacosamide—Diarrhoea—Etoposide—hematologic cancer	1.21e-05	0.000176	CcSEcCtD
Lacosamide—Eye disorder—Doxorubicin—hematologic cancer	1.2e-05	0.000176	CcSEcCtD
Lacosamide—Tinnitus—Doxorubicin—hematologic cancer	1.2e-05	0.000175	CcSEcCtD
Lacosamide—Anaemia—Methotrexate—hematologic cancer	1.2e-05	0.000175	CcSEcCtD
Lacosamide—Feeling abnormal—Betamethasone—hematologic cancer	1.19e-05	0.000175	CcSEcCtD
Lacosamide—Feeling abnormal—Dexamethasone—hematologic cancer	1.19e-05	0.000175	CcSEcCtD
Lacosamide—Cardiac disorder—Doxorubicin—hematologic cancer	1.19e-05	0.000174	CcSEcCtD
Lacosamide—Flatulence—Epirubicin—hematologic cancer	1.19e-05	0.000174	CcSEcCtD
Lacosamide—Hypersensitivity—Triamcinolone—hematologic cancer	1.18e-05	0.000172	CcSEcCtD
Lacosamide—Dizziness—Etoposide—hematologic cancer	1.16e-05	0.00017	CcSEcCtD
Lacosamide—Muscle spasms—Epirubicin—hematologic cancer	1.16e-05	0.00017	CcSEcCtD
Lacosamide—Immune system disorder—Doxorubicin—hematologic cancer	1.16e-05	0.00017	CcSEcCtD
Lacosamide—Vertigo—Methotrexate—hematologic cancer	1.16e-05	0.00017	CcSEcCtD
Lacosamide—Urticaria—Dexamethasone—hematologic cancer	1.15e-05	0.000168	CcSEcCtD
Lacosamide—Urticaria—Betamethasone—hematologic cancer	1.15e-05	0.000168	CcSEcCtD
Lacosamide—Dizziness—Prednisolone—hematologic cancer	1.15e-05	0.000168	CcSEcCtD
Lacosamide—Asthenia—Triamcinolone—hematologic cancer	1.15e-05	0.000167	CcSEcCtD
Lacosamide—Body temperature increased—Betamethasone—hematologic cancer	1.15e-05	0.000167	CcSEcCtD
Lacosamide—Body temperature increased—Dexamethasone—hematologic cancer	1.15e-05	0.000167	CcSEcCtD
Lacosamide—Nausea—Cisplatin—hematologic cancer	1.14e-05	0.000167	CcSEcCtD
Lacosamide—Insomnia—Prednisone—hematologic cancer	1.14e-05	0.000167	CcSEcCtD
Lacosamide—Vision blurred—Epirubicin—hematologic cancer	1.14e-05	0.000167	CcSEcCtD
Lacosamide—Paraesthesia—Prednisone—hematologic cancer	1.13e-05	0.000166	CcSEcCtD
Lacosamide—Pruritus—Triamcinolone—hematologic cancer	1.13e-05	0.000165	CcSEcCtD
Lacosamide—Mental disorder—Doxorubicin—hematologic cancer	1.13e-05	0.000165	CcSEcCtD
Lacosamide—Vomiting—Etoposide—hematologic cancer	1.12e-05	0.000164	CcSEcCtD
Lacosamide—Erythema—Doxorubicin—hematologic cancer	1.12e-05	0.000164	CcSEcCtD
Lacosamide—Anaemia—Epirubicin—hematologic cancer	1.12e-05	0.000163	CcSEcCtD
Lacosamide—Agitation—Epirubicin—hematologic cancer	1.11e-05	0.000162	CcSEcCtD
Lacosamide—Dyspepsia—Prednisone—hematologic cancer	1.11e-05	0.000162	CcSEcCtD
Lacosamide—Rash—Etoposide—hematologic cancer	1.11e-05	0.000162	CcSEcCtD
Lacosamide—Dermatitis—Etoposide—hematologic cancer	1.11e-05	0.000162	CcSEcCtD
Lacosamide—Headache—Etoposide—hematologic cancer	1.1e-05	0.000161	CcSEcCtD
Lacosamide—Flatulence—Doxorubicin—hematologic cancer	1.1e-05	0.000161	CcSEcCtD
Lacosamide—Chest pain—Methotrexate—hematologic cancer	1.1e-05	0.000161	CcSEcCtD
Lacosamide—Rash—Prednisolone—hematologic cancer	1.1e-05	0.00016	CcSEcCtD
Lacosamide—Dermatitis—Prednisolone—hematologic cancer	1.09e-05	0.00016	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.09e-05	0.00016	CcSEcCtD
Lacosamide—Fatigue—Prednisone—hematologic cancer	1.09e-05	0.000159	CcSEcCtD
Lacosamide—Headache—Prednisolone—hematologic cancer	1.09e-05	0.000159	CcSEcCtD
Lacosamide—Discomfort—Methotrexate—hematologic cancer	1.09e-05	0.000159	CcSEcCtD
Lacosamide—Vertigo—Epirubicin—hematologic cancer	1.09e-05	0.000159	CcSEcCtD
Lacosamide—Syncope—Epirubicin—hematologic cancer	1.09e-05	0.000159	CcSEcCtD
Lacosamide—Constipation—Prednisone—hematologic cancer	1.08e-05	0.000158	CcSEcCtD
Lacosamide—Muscle spasms—Doxorubicin—hematologic cancer	1.08e-05	0.000157	CcSEcCtD
Lacosamide—Palpitations—Epirubicin—hematologic cancer	1.07e-05	0.000156	CcSEcCtD
Lacosamide—Confusional state—Methotrexate—hematologic cancer	1.06e-05	0.000155	CcSEcCtD
Lacosamide—Loss of consciousness—Epirubicin—hematologic cancer	1.06e-05	0.000155	CcSEcCtD
Lacosamide—Dizziness—Triamcinolone—hematologic cancer	1.06e-05	0.000154	CcSEcCtD
Lacosamide—Vision blurred—Doxorubicin—hematologic cancer	1.06e-05	0.000154	CcSEcCtD
Lacosamide—Nausea—Etoposide—hematologic cancer	1.05e-05	0.000153	CcSEcCtD
Lacosamide—Feeling abnormal—Prednisone—hematologic cancer	1.04e-05	0.000152	CcSEcCtD
Lacosamide—Asthenia—Dexamethasone—hematologic cancer	1.04e-05	0.000152	CcSEcCtD
Lacosamide—Asthenia—Betamethasone—hematologic cancer	1.04e-05	0.000152	CcSEcCtD
Lacosamide—Nervous system disorder—Methotrexate—hematologic cancer	1.03e-05	0.000151	CcSEcCtD
Lacosamide—Anaemia—Doxorubicin—hematologic cancer	1.03e-05	0.000151	CcSEcCtD
Lacosamide—Nausea—Prednisolone—hematologic cancer	1.03e-05	0.000151	CcSEcCtD
Lacosamide—Chest pain—Epirubicin—hematologic cancer	1.03e-05	0.00015	CcSEcCtD
Lacosamide—Agitation—Doxorubicin—hematologic cancer	1.03e-05	0.00015	CcSEcCtD
Lacosamide—Pruritus—Betamethasone—hematologic cancer	1.03e-05	0.00015	CcSEcCtD
Lacosamide—Pruritus—Dexamethasone—hematologic cancer	1.03e-05	0.00015	CcSEcCtD
Lacosamide—Skin disorder—Methotrexate—hematologic cancer	1.02e-05	0.00015	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.02e-05	0.000149	CcSEcCtD
Lacosamide—Hyperhidrosis—Methotrexate—hematologic cancer	1.02e-05	0.000149	CcSEcCtD
Lacosamide—Discomfort—Epirubicin—hematologic cancer	1.02e-05	0.000149	CcSEcCtD
Lacosamide—Vomiting—Triamcinolone—hematologic cancer	1.02e-05	0.000148	CcSEcCtD
Lacosamide—Rash—Triamcinolone—hematologic cancer	1.01e-05	0.000147	CcSEcCtD
Lacosamide—Dry mouth—Epirubicin—hematologic cancer	1.01e-05	0.000147	CcSEcCtD
Lacosamide—Dermatitis—Triamcinolone—hematologic cancer	1.01e-05	0.000147	CcSEcCtD
Lacosamide—Vertigo—Doxorubicin—hematologic cancer	1.01e-05	0.000147	CcSEcCtD
Lacosamide—Syncope—Doxorubicin—hematologic cancer	1e-05	0.000147	CcSEcCtD
Lacosamide—Urticaria—Prednisone—hematologic cancer	1e-05	0.000147	CcSEcCtD
Lacosamide—Headache—Triamcinolone—hematologic cancer	1e-05	0.000146	CcSEcCtD
Lacosamide—Body temperature increased—Prednisone—hematologic cancer	9.98e-06	0.000146	CcSEcCtD
Lacosamide—Confusional state—Epirubicin—hematologic cancer	9.96e-06	0.000145	CcSEcCtD
Lacosamide—Diarrhoea—Dexamethasone—hematologic cancer	9.92e-06	0.000145	CcSEcCtD
Lacosamide—Diarrhoea—Betamethasone—hematologic cancer	9.92e-06	0.000145	CcSEcCtD
Lacosamide—Palpitations—Doxorubicin—hematologic cancer	9.89e-06	0.000145	CcSEcCtD
Lacosamide—Loss of consciousness—Doxorubicin—hematologic cancer	9.84e-06	0.000144	CcSEcCtD
Lacosamide—Shock—Epirubicin—hematologic cancer	9.72e-06	0.000142	CcSEcCtD
Lacosamide—Nervous system disorder—Epirubicin—hematologic cancer	9.68e-06	0.000141	CcSEcCtD
Lacosamide—Skin disorder—Epirubicin—hematologic cancer	9.59e-06	0.00014	CcSEcCtD
Lacosamide—Dizziness—Dexamethasone—hematologic cancer	9.59e-06	0.00014	CcSEcCtD
Lacosamide—Dizziness—Betamethasone—hematologic cancer	9.59e-06	0.00014	CcSEcCtD
Lacosamide—Hyperhidrosis—Epirubicin—hematologic cancer	9.55e-06	0.000139	CcSEcCtD
Lacosamide—Insomnia—Methotrexate—hematologic cancer	9.54e-06	0.000139	CcSEcCtD
Lacosamide—Chest pain—Doxorubicin—hematologic cancer	9.53e-06	0.000139	CcSEcCtD
Lacosamide—Nausea—Triamcinolone—hematologic cancer	9.49e-06	0.000139	CcSEcCtD
Lacosamide—Paraesthesia—Methotrexate—hematologic cancer	9.48e-06	0.000138	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	9.47e-06	0.000138	CcSEcCtD
Lacosamide—Discomfort—Doxorubicin—hematologic cancer	9.42e-06	0.000138	CcSEcCtD
Lacosamide—Somnolence—Methotrexate—hematologic cancer	9.38e-06	0.000137	CcSEcCtD
Lacosamide—Dry mouth—Doxorubicin—hematologic cancer	9.32e-06	0.000136	CcSEcCtD
Lacosamide—Hypersensitivity—Prednisone—hematologic cancer	9.3e-06	0.000136	CcSEcCtD
Lacosamide—Dyspepsia—Methotrexate—hematologic cancer	9.29e-06	0.000136	CcSEcCtD
Lacosamide—Vomiting—Dexamethasone—hematologic cancer	9.22e-06	0.000135	CcSEcCtD
Lacosamide—Vomiting—Betamethasone—hematologic cancer	9.22e-06	0.000135	CcSEcCtD
Lacosamide—Confusional state—Doxorubicin—hematologic cancer	9.21e-06	0.000135	CcSEcCtD
Lacosamide—Rash—Dexamethasone—hematologic cancer	9.14e-06	0.000134	CcSEcCtD
Lacosamide—Rash—Betamethasone—hematologic cancer	9.14e-06	0.000134	CcSEcCtD
Lacosamide—Dermatitis—Dexamethasone—hematologic cancer	9.13e-06	0.000133	CcSEcCtD
Lacosamide—Dermatitis—Betamethasone—hematologic cancer	9.13e-06	0.000133	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Methotrexate—hematologic cancer	9.11e-06	0.000133	CcSEcCtD
Lacosamide—Fatigue—Methotrexate—hematologic cancer	9.1e-06	0.000133	CcSEcCtD
Lacosamide—Headache—Dexamethasone—hematologic cancer	9.08e-06	0.000133	CcSEcCtD
Lacosamide—Headache—Betamethasone—hematologic cancer	9.08e-06	0.000133	CcSEcCtD
Lacosamide—Asthenia—Prednisone—hematologic cancer	9.06e-06	0.000132	CcSEcCtD
Lacosamide—Shock—Doxorubicin—hematologic cancer	8.99e-06	0.000131	CcSEcCtD
Lacosamide—Nervous system disorder—Doxorubicin—hematologic cancer	8.96e-06	0.000131	CcSEcCtD
Lacosamide—Pruritus—Prednisone—hematologic cancer	8.93e-06	0.000131	CcSEcCtD
Lacosamide—Insomnia—Epirubicin—hematologic cancer	8.93e-06	0.00013	CcSEcCtD
Lacosamide—Skin disorder—Doxorubicin—hematologic cancer	8.88e-06	0.00013	CcSEcCtD
Lacosamide—Paraesthesia—Epirubicin—hematologic cancer	8.87e-06	0.00013	CcSEcCtD
Lacosamide—Hyperhidrosis—Doxorubicin—hematologic cancer	8.83e-06	0.000129	CcSEcCtD
Lacosamide—Somnolence—Epirubicin—hematologic cancer	8.78e-06	0.000128	CcSEcCtD
Lacosamide—Feeling abnormal—Methotrexate—hematologic cancer	8.7e-06	0.000127	CcSEcCtD
Lacosamide—Dyspepsia—Epirubicin—hematologic cancer	8.69e-06	0.000127	CcSEcCtD
Lacosamide—Diarrhoea—Prednisone—hematologic cancer	8.64e-06	0.000126	CcSEcCtD
Lacosamide—Nausea—Dexamethasone—hematologic cancer	8.61e-06	0.000126	CcSEcCtD
Lacosamide—Nausea—Betamethasone—hematologic cancer	8.61e-06	0.000126	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Epirubicin—hematologic cancer	8.53e-06	0.000125	CcSEcCtD
Lacosamide—Fatigue—Epirubicin—hematologic cancer	8.51e-06	0.000124	CcSEcCtD
Lacosamide—Constipation—Epirubicin—hematologic cancer	8.44e-06	0.000123	CcSEcCtD
Lacosamide—SCN3A—Developmental Biology—MAP2K1—hematologic cancer	8.44e-06	0.000353	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—CREB1—hematologic cancer	8.41e-06	0.000352	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—FGF2—hematologic cancer	8.39e-06	0.000351	CbGpPWpGaD
Lacosamide—CA4—Metabolism—NUP214—hematologic cancer	8.39e-06	0.000351	CbGpPWpGaD
Lacosamide—Urticaria—Methotrexate—hematologic cancer	8.38e-06	0.000122	CcSEcCtD
Lacosamide—SCN9A—Axon guidance—VEGFA—hematologic cancer	8.36e-06	0.000349	CbGpPWpGaD
Lacosamide—Dizziness—Prednisone—hematologic cancer	8.35e-06	0.000122	CcSEcCtD
Lacosamide—CA2—Metabolism—NUP98—hematologic cancer	8.35e-06	0.000349	CbGpPWpGaD
Lacosamide—Body temperature increased—Methotrexate—hematologic cancer	8.34e-06	0.000122	CcSEcCtD
Lacosamide—CA5B—Metabolism—CYCS—hematologic cancer	8.32e-06	0.000348	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—HSP90AA1—hematologic cancer	8.27e-06	0.000346	CbGpPWpGaD
Lacosamide—Insomnia—Doxorubicin—hematologic cancer	8.26e-06	0.000121	CcSEcCtD
Lacosamide—CA1—Metabolism—ALOX5—hematologic cancer	8.26e-06	0.000345	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—NRAS—hematologic cancer	8.26e-06	0.000345	CbGpPWpGaD
Lacosamide—CA9—Metabolism—IDH1—hematologic cancer	8.24e-06	0.000344	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—CDKN1A—hematologic cancer	8.23e-06	0.000344	CbGpPWpGaD
Lacosamide—CA4—Metabolism—MTR—hematologic cancer	8.22e-06	0.000344	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ABCG2—hematologic cancer	8.22e-06	0.000344	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—SRC—hematologic cancer	8.21e-06	0.000343	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—IL6R—hematologic cancer	8.21e-06	0.000343	CbGpPWpGaD
Lacosamide—Paraesthesia—Doxorubicin—hematologic cancer	8.2e-06	0.00012	CcSEcCtD
Lacosamide—SCN10A—Developmental Biology—CREBBP—hematologic cancer	8.19e-06	0.000342	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ABCC3—hematologic cancer	8.15e-06	0.000341	CbGpPWpGaD
Lacosamide—CA9—Metabolism—TXN—hematologic cancer	8.15e-06	0.000341	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GSTO1—hematologic cancer	8.15e-06	0.000341	CbGpPWpGaD
Lacosamide—Feeling abnormal—Epirubicin—hematologic cancer	8.14e-06	0.000119	CcSEcCtD
Lacosamide—Somnolence—Doxorubicin—hematologic cancer	8.12e-06	0.000119	CcSEcCtD
Lacosamide—CA2—Metabolism—ADCY7—hematologic cancer	8.1e-06	0.000339	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NCOA3—hematologic cancer	8.1e-06	0.000339	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GSTP1—hematologic cancer	8.06e-06	0.000337	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ENO2—hematologic cancer	8.06e-06	0.000337	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—JAK2—hematologic cancer	8.05e-06	0.000336	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NUP214—hematologic cancer	8.05e-06	0.000336	CbGpPWpGaD
Lacosamide—Dyspepsia—Doxorubicin—hematologic cancer	8.04e-06	0.000118	CcSEcCtD
Lacosamide—CA9—Cellular responses to stress—MAPK8—hematologic cancer	8.03e-06	0.000336	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—FGF2—hematologic cancer	8.03e-06	0.000336	CbGpPWpGaD
Lacosamide—Vomiting—Prednisone—hematologic cancer	8.03e-06	0.000117	CcSEcCtD
Lacosamide—CA1—Metabolism—NUP98—hematologic cancer	8e-06	0.000334	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—VEGFA—hematologic cancer	7.99e-06	0.000334	CbGpPWpGaD
Lacosamide—CA9—Metabolism—SPHK1—hematologic cancer	7.97e-06	0.000333	CbGpPWpGaD
Lacosamide—Rash—Prednisone—hematologic cancer	7.96e-06	0.000116	CcSEcCtD
Lacosamide—Dermatitis—Prednisone—hematologic cancer	7.95e-06	0.000116	CcSEcCtD
Lacosamide—CA3—Metabolism—CREBBP—hematologic cancer	7.92e-06	0.000331	CbGpPWpGaD
Lacosamide—Headache—Prednisone—hematologic cancer	7.91e-06	0.000116	CcSEcCtD
Lacosamide—SCN9A—Axon guidance—MAPK3—hematologic cancer	7.91e-06	0.00033	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—NRAS—hematologic cancer	7.9e-06	0.00033	CbGpPWpGaD
Lacosamide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	7.89e-06	0.000115	CcSEcCtD
Lacosamide—CA2—Metabolism—MTR—hematologic cancer	7.88e-06	0.000329	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ABCG2—hematologic cancer	7.88e-06	0.000329	CbGpPWpGaD
Lacosamide—Fatigue—Doxorubicin—hematologic cancer	7.88e-06	0.000115	CcSEcCtD
Lacosamide—CA6—Metabolism—GSTP1—hematologic cancer	7.86e-06	0.000328	CbGpPWpGaD
Lacosamide—Urticaria—Epirubicin—hematologic cancer	7.84e-06	0.000115	CcSEcCtD
Lacosamide—CA9—Cellular responses to stress—EP300—hematologic cancer	7.83e-06	0.000327	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—MAP2K1—hematologic cancer	7.82e-06	0.000327	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GSTT1—hematologic cancer	7.82e-06	0.000327	CbGpPWpGaD
Lacosamide—Constipation—Doxorubicin—hematologic cancer	7.81e-06	0.000114	CcSEcCtD
Lacosamide—Body temperature increased—Epirubicin—hematologic cancer	7.81e-06	0.000114	CcSEcCtD
Lacosamide—Hypersensitivity—Methotrexate—hematologic cancer	7.77e-06	0.000114	CcSEcCtD
Lacosamide—CA1—Metabolism—ADCY7—hematologic cancer	7.77e-06	0.000325	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NCOA3—hematologic cancer	7.77e-06	0.000325	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ENO2—hematologic cancer	7.73e-06	0.000323	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NUP214—hematologic cancer	7.71e-06	0.000322	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—JAK2—hematologic cancer	7.7e-06	0.000322	CbGpPWpGaD
Lacosamide—CA9—Metabolism—UGT1A1—hematologic cancer	7.66e-06	0.00032	CbGpPWpGaD
Lacosamide—CA4—Metabolism—SDC1—hematologic cancer	7.64e-06	0.000319	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ABCB1—hematologic cancer	7.63e-06	0.000319	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—SRC—hematologic cancer	7.6e-06	0.000318	CbGpPWpGaD
Lacosamide—Asthenia—Methotrexate—hematologic cancer	7.57e-06	0.000111	CcSEcCtD
Lacosamide—SCN3A—Axon guidance—MAPK3—hematologic cancer	7.56e-06	0.000316	CbGpPWpGaD
Lacosamide—CA1—Metabolism—MTR—hematologic cancer	7.56e-06	0.000316	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ABCG2—hematologic cancer	7.56e-06	0.000316	CbGpPWpGaD
Lacosamide—Feeling abnormal—Doxorubicin—hematologic cancer	7.53e-06	0.00011	CcSEcCtD
Lacosamide—CA3—Metabolism—PIK3CD—hematologic cancer	7.51e-06	0.000314	CbGpPWpGaD
Lacosamide—Nausea—Prednisone—hematologic cancer	7.5e-06	0.00011	CcSEcCtD
Lacosamide—CA2—Metabolism—GSTT1—hematologic cancer	7.5e-06	0.000313	CbGpPWpGaD
Lacosamide—Pruritus—Methotrexate—hematologic cancer	7.47e-06	0.000109	CcSEcCtD
Lacosamide—CA9—Metabolism—CRABP1—hematologic cancer	7.45e-06	0.000311	CbGpPWpGaD
Lacosamide—CA9—Metabolism—SLC22A1—hematologic cancer	7.45e-06	0.000311	CbGpPWpGaD
Lacosamide—CA6—Metabolism—ABCB1—hematologic cancer	7.44e-06	0.000311	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—FGF2—hematologic cancer	7.44e-06	0.000311	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—VEGFA—hematologic cancer	7.42e-06	0.00031	CbGpPWpGaD
Lacosamide—CA14—Metabolism—NCOR1—hematologic cancer	7.41e-06	0.00031	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ENO2—hematologic cancer	7.41e-06	0.00031	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GSTM1—hematologic cancer	7.41e-06	0.00031	CbGpPWpGaD
Lacosamide—CA3—Metabolism—ALB—hematologic cancer	7.41e-06	0.00031	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—VEGFA—hematologic cancer	7.41e-06	0.00031	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—STAT3—hematologic cancer	7.35e-06	0.000307	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—GSTP1—hematologic cancer	7.34e-06	0.000307	CbGpPWpGaD
Lacosamide—CA2—Metabolism—SDC1—hematologic cancer	7.33e-06	0.000306	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—NRAS—hematologic cancer	7.32e-06	0.000306	CbGpPWpGaD
Lacosamide—Hypersensitivity—Epirubicin—hematologic cancer	7.28e-06	0.000106	CcSEcCtD
Lacosamide—CA9—Metabolism—ALOX5—hematologic cancer	7.26e-06	0.000304	CbGpPWpGaD
Lacosamide—Urticaria—Doxorubicin—hematologic cancer	7.26e-06	0.000106	CcSEcCtD
Lacosamide—Body temperature increased—Doxorubicin—hematologic cancer	7.22e-06	0.000106	CcSEcCtD
Lacosamide—CA6—Metabolism—GSTM1—hematologic cancer	7.22e-06	0.000302	CbGpPWpGaD
Lacosamide—CA6—Metabolism—NCOR1—hematologic cancer	7.22e-06	0.000302	CbGpPWpGaD
Lacosamide—Diarrhoea—Methotrexate—hematologic cancer	7.22e-06	0.000105	CcSEcCtD
Lacosamide—CA1—Metabolism—GSTT1—hematologic cancer	7.19e-06	0.0003	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—JAK2—hematologic cancer	7.13e-06	0.000298	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—KRAS—hematologic cancer	7.11e-06	0.000297	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PIK3R1—hematologic cancer	7.09e-06	0.000296	CbGpPWpGaD
Lacosamide—Asthenia—Epirubicin—hematologic cancer	7.09e-06	0.000104	CcSEcCtD
Lacosamide—CA9—Metabolism—NUP98—hematologic cancer	7.03e-06	0.000294	CbGpPWpGaD
Lacosamide—CA1—Metabolism—SDC1—hematologic cancer	7.03e-06	0.000294	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—MAPK3—hematologic cancer	7.02e-06	0.000293	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—MAPK3—hematologic cancer	7.01e-06	0.000293	CbGpPWpGaD
Lacosamide—Pruritus—Epirubicin—hematologic cancer	6.99e-06	0.000102	CcSEcCtD
Lacosamide—Dizziness—Methotrexate—hematologic cancer	6.98e-06	0.000102	CcSEcCtD
Lacosamide—CA5B—Metabolism—ABCB1—hematologic cancer	6.94e-06	0.00029	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ADCY7—hematologic cancer	6.83e-06	0.000285	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NCOA3—hematologic cancer	6.83e-06	0.000285	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—KRAS—hematologic cancer	6.8e-06	0.000284	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NUP214—hematologic cancer	6.78e-06	0.000283	CbGpPWpGaD
Lacosamide—Diarrhoea—Epirubicin—hematologic cancer	6.76e-06	9.87e-05	CcSEcCtD
Lacosamide—CA5B—Metabolism—GSTM1—hematologic cancer	6.74e-06	0.000282	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—NCOR1—hematologic cancer	6.74e-06	0.000282	CbGpPWpGaD
Lacosamide—Hypersensitivity—Doxorubicin—hematologic cancer	6.73e-06	9.84e-05	CcSEcCtD
Lacosamide—Vomiting—Methotrexate—hematologic cancer	6.71e-06	9.8e-05	CcSEcCtD
Lacosamide—Rash—Methotrexate—hematologic cancer	6.65e-06	9.72e-05	CcSEcCtD
Lacosamide—Dermatitis—Methotrexate—hematologic cancer	6.65e-06	9.71e-05	CcSEcCtD
Lacosamide—CA9—Metabolism—ABCG2—hematologic cancer	6.64e-06	0.000278	CbGpPWpGaD
Lacosamide—CA9—Metabolism—MTR—hematologic cancer	6.64e-06	0.000278	CbGpPWpGaD
Lacosamide—Headache—Methotrexate—hematologic cancer	6.61e-06	9.66e-05	CcSEcCtD
Lacosamide—Asthenia—Doxorubicin—hematologic cancer	6.56e-06	9.58e-05	CcSEcCtD
Lacosamide—CA14—Metabolism—MTHFR—hematologic cancer	6.55e-06	0.000274	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PIK3CB—hematologic cancer	6.54e-06	0.000273	CbGpPWpGaD
Lacosamide—Dizziness—Epirubicin—hematologic cancer	6.53e-06	9.54e-05	CcSEcCtD
Lacosamide—CA9—Metabolism—ENO2—hematologic cancer	6.51e-06	0.000272	CbGpPWpGaD
Lacosamide—CA4—Metabolism—CD44—hematologic cancer	6.5e-06	0.000272	CbGpPWpGaD
Lacosamide—CA4—Metabolism—NQO1—hematologic cancer	6.5e-06	0.000272	CbGpPWpGaD
Lacosamide—Pruritus—Doxorubicin—hematologic cancer	6.46e-06	9.44e-05	CcSEcCtD
Lacosamide—CA6—Metabolism—MTHFR—hematologic cancer	6.38e-06	0.000267	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GSTT1—hematologic cancer	6.32e-06	0.000264	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—EP300—hematologic cancer	6.3e-06	0.000263	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—KRAS—hematologic cancer	6.3e-06	0.000263	CbGpPWpGaD
Lacosamide—Vomiting—Epirubicin—hematologic cancer	6.28e-06	9.17e-05	CcSEcCtD
Lacosamide—Nausea—Methotrexate—hematologic cancer	6.27e-06	9.16e-05	CcSEcCtD
Lacosamide—Diarrhoea—Doxorubicin—hematologic cancer	6.25e-06	9.13e-05	CcSEcCtD
Lacosamide—CA2—Metabolism—NQO1—hematologic cancer	6.23e-06	0.00026	CbGpPWpGaD
Lacosamide—CA2—Metabolism—CD44—hematologic cancer	6.23e-06	0.00026	CbGpPWpGaD
Lacosamide—Rash—Epirubicin—hematologic cancer	6.23e-06	9.1e-05	CcSEcCtD
Lacosamide—Dermatitis—Epirubicin—hematologic cancer	6.22e-06	9.09e-05	CcSEcCtD
Lacosamide—Headache—Epirubicin—hematologic cancer	6.19e-06	9.04e-05	CcSEcCtD
Lacosamide—CA9—Metabolism—SDC1—hematologic cancer	6.18e-06	0.000258	CbGpPWpGaD
Lacosamide—CA4—Metabolism—CYCS—hematologic cancer	6.15e-06	0.000257	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—SRC—hematologic cancer	6.12e-06	0.000256	CbGpPWpGaD
Lacosamide—CA4—Metabolism—HSP90AA1—hematologic cancer	6.11e-06	0.000255	CbGpPWpGaD
Lacosamide—Dizziness—Doxorubicin—hematologic cancer	6.04e-06	8.83e-05	CcSEcCtD
Lacosamide—SCN9A—Axon guidance—HRAS—hematologic cancer	6.04e-06	0.000252	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—EP300—hematologic cancer	6.02e-06	0.000252	CbGpPWpGaD
Lacosamide—CA1—Metabolism—CD44—hematologic cancer	5.97e-06	0.00025	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NQO1—hematologic cancer	5.97e-06	0.00025	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—VEGFA—hematologic cancer	5.96e-06	0.000249	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—MTHFR—hematologic cancer	5.96e-06	0.000249	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—STAT3—hematologic cancer	5.91e-06	0.000247	CbGpPWpGaD
Lacosamide—CA2—Metabolism—CYCS—hematologic cancer	5.9e-06	0.000246	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—NRAS—hematologic cancer	5.89e-06	0.000246	CbGpPWpGaD
Lacosamide—Nausea—Epirubicin—hematologic cancer	5.87e-06	8.57e-05	CcSEcCtD
Lacosamide—CA2—Metabolism—HSP90AA1—hematologic cancer	5.86e-06	0.000245	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—SRC—hematologic cancer	5.86e-06	0.000245	CbGpPWpGaD
Lacosamide—Vomiting—Doxorubicin—hematologic cancer	5.81e-06	8.49e-05	CcSEcCtD
Lacosamide—SCN9A—Axon guidance—IL6—hematologic cancer	5.78e-06	0.000242	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—HRAS—hematologic cancer	5.78e-06	0.000241	CbGpPWpGaD
Lacosamide—Rash—Doxorubicin—hematologic cancer	5.76e-06	8.42e-05	CcSEcCtD
Lacosamide—Dermatitis—Doxorubicin—hematologic cancer	5.76e-06	8.41e-05	CcSEcCtD
Lacosamide—Headache—Doxorubicin—hematologic cancer	5.72e-06	8.36e-05	CcSEcCtD
Lacosamide—SCN3A—Developmental Biology—VEGFA—hematologic cancer	5.7e-06	0.000238	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PTEN—hematologic cancer	5.65e-06	0.000236	CbGpPWpGaD
Lacosamide—CA1—Metabolism—CYCS—hematologic cancer	5.65e-06	0.000236	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—STAT3—hematologic cancer	5.65e-06	0.000236	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—MAPK3—hematologic cancer	5.64e-06	0.000236	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—NRAS—hematologic cancer	5.63e-06	0.000235	CbGpPWpGaD
Lacosamide—CA1—Metabolism—HSP90AA1—hematologic cancer	5.62e-06	0.000235	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—TP53—hematologic cancer	5.61e-06	0.000234	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—EP300—hematologic cancer	5.58e-06	0.000233	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—IL6—hematologic cancer	5.53e-06	0.000231	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PIK3CG—hematologic cancer	5.5e-06	0.00023	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—TGFB1—hematologic cancer	5.47e-06	0.000229	CbGpPWpGaD
Lacosamide—Nausea—Doxorubicin—hematologic cancer	5.43e-06	7.93e-05	CcSEcCtD
Lacosamide—SCN10A—Developmental Biology—SRC—hematologic cancer	5.43e-06	0.000227	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GSTP1—hematologic cancer	5.42e-06	0.000227	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—MAPK3—hematologic cancer	5.4e-06	0.000226	CbGpPWpGaD
Lacosamide—CA3—Metabolism—EP300—hematologic cancer	5.39e-06	0.000225	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PIK3CG—hematologic cancer	5.36e-06	0.000224	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—HRAS—hematologic cancer	5.35e-06	0.000224	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—VEGFA—hematologic cancer	5.29e-06	0.000221	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NQO1—hematologic cancer	5.25e-06	0.000219	CbGpPWpGaD
Lacosamide—CA9—Metabolism—CD44—hematologic cancer	5.25e-06	0.000219	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—TGFB1—hematologic cancer	5.24e-06	0.000219	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—STAT3—hematologic cancer	5.23e-06	0.000219	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—NRAS—hematologic cancer	5.22e-06	0.000218	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GSTP1—hematologic cancer	5.2e-06	0.000217	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—IL6—hematologic cancer	5.13e-06	0.000214	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ABCB1—hematologic cancer	5.13e-06	0.000214	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—IL6—hematologic cancer	5.12e-06	0.000214	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—TNF—hematologic cancer	5.11e-06	0.000214	CbGpPWpGaD
Lacosamide—CA14—Metabolism—CREBBP—hematologic cancer	5.1e-06	0.000213	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—KRAS—hematologic cancer	5.07e-06	0.000212	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PIK3CG—hematologic cancer	5.01e-06	0.000209	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—MAPK3—hematologic cancer	5e-06	0.000209	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GSTP1—hematologic cancer	4.98e-06	0.000208	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GSTM1—hematologic cancer	4.98e-06	0.000208	CbGpPWpGaD
Lacosamide—CA4—Metabolism—NCOR1—hematologic cancer	4.98e-06	0.000208	CbGpPWpGaD
Lacosamide—CA6—Metabolism—CREBBP—hematologic cancer	4.97e-06	0.000208	CbGpPWpGaD
Lacosamide—CA9—Metabolism—CYCS—hematologic cancer	4.97e-06	0.000208	CbGpPWpGaD
Lacosamide—CA9—Metabolism—HSP90AA1—hematologic cancer	4.94e-06	0.000206	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ABCB1—hematologic cancer	4.92e-06	0.000206	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—TNF—hematologic cancer	4.89e-06	0.000204	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—TGFB1—hematologic cancer	4.85e-06	0.000203	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—KRAS—hematologic cancer	4.85e-06	0.000203	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PIK3CD—hematologic cancer	4.84e-06	0.000202	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ALB—hematologic cancer	4.78e-06	0.0002	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NCOR1—hematologic cancer	4.78e-06	0.0002	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GSTM1—hematologic cancer	4.78e-06	0.0002	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ABCB1—hematologic cancer	4.72e-06	0.000197	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PIK3CD—hematologic cancer	4.71e-06	0.000197	CbGpPWpGaD
Lacosamide—CA6—Metabolism—ALB—hematologic cancer	4.65e-06	0.000194	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—CREBBP—hematologic cancer	4.64e-06	0.000194	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NCOR1—hematologic cancer	4.58e-06	0.000191	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GSTM1—hematologic cancer	4.58e-06	0.000191	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PIK3R1—hematologic cancer	4.57e-06	0.000191	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—TNF—hematologic cancer	4.53e-06	0.000189	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—KRAS—hematologic cancer	4.49e-06	0.000188	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PIK3R1—hematologic cancer	4.45e-06	0.000186	CbGpPWpGaD
Lacosamide—CA4—Metabolism—MTHFR—hematologic cancer	4.4e-06	0.000184	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PIK3CD—hematologic cancer	4.4e-06	0.000184	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GSTP1—hematologic cancer	4.38e-06	0.000183	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—ALB—hematologic cancer	4.34e-06	0.000182	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—HRAS—hematologic cancer	4.31e-06	0.00018	CbGpPWpGaD
Lacosamide—CA2—Metabolism—MTHFR—hematologic cancer	4.22e-06	0.000176	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PIK3CB—hematologic cancer	4.22e-06	0.000176	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PIK3R1—hematologic cancer	4.16e-06	0.000174	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ABCB1—hematologic cancer	4.15e-06	0.000173	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—IL6—hematologic cancer	4.13e-06	0.000172	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—HRAS—hematologic cancer	4.12e-06	0.000172	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PIK3CB—hematologic cancer	4.11e-06	0.000172	CbGpPWpGaD
Lacosamide—CA1—Metabolism—MTHFR—hematologic cancer	4.05e-06	0.000169	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GSTM1—hematologic cancer	4.02e-06	0.000168	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NCOR1—hematologic cancer	4.02e-06	0.000168	CbGpPWpGaD
Lacosamide—CA3—Metabolism—PIK3CA—hematologic cancer	3.99e-06	0.000167	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—IL6—hematologic cancer	3.95e-06	0.000165	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PIK3CB—hematologic cancer	3.84e-06	0.00016	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—HRAS—hematologic cancer	3.82e-06	0.00016	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—AKT1—hematologic cancer	3.81e-06	0.000159	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PIK3CG—hematologic cancer	3.7e-06	0.000155	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—IL6—hematologic cancer	3.66e-06	0.000153	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PTEN—hematologic cancer	3.64e-06	0.000152	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—AKT1—hematologic cancer	3.64e-06	0.000152	CbGpPWpGaD
Lacosamide—CA9—Metabolism—MTHFR—hematologic cancer	3.56e-06	0.000149	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PTEN—hematologic cancer	3.55e-06	0.000148	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PIK3CG—hematologic cancer	3.55e-06	0.000148	CbGpPWpGaD
Lacosamide—CA14—Metabolism—EP300—hematologic cancer	3.47e-06	0.000145	CbGpPWpGaD
Lacosamide—CA4—Metabolism—CREBBP—hematologic cancer	3.43e-06	0.000143	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PIK3CG—hematologic cancer	3.4e-06	0.000142	CbGpPWpGaD
Lacosamide—CA6—Metabolism—EP300—hematologic cancer	3.39e-06	0.000142	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—AKT1—hematologic cancer	3.37e-06	0.000141	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PTEN—hematologic cancer	3.31e-06	0.000139	CbGpPWpGaD
Lacosamide—CA2—Metabolism—CREBBP—hematologic cancer	3.29e-06	0.000137	CbGpPWpGaD
Lacosamide—CA3—Metabolism—AKT1—hematologic cancer	3.26e-06	0.000136	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PIK3CD—hematologic cancer	3.25e-06	0.000136	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ALB—hematologic cancer	3.21e-06	0.000134	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—EP300—hematologic cancer	3.16e-06	0.000132	CbGpPWpGaD
Lacosamide—CA1—Metabolism—CREBBP—hematologic cancer	3.15e-06	0.000132	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PIK3CD—hematologic cancer	3.12e-06	0.00013	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ALB—hematologic cancer	3.08e-06	0.000129	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PIK3R1—hematologic cancer	3.07e-06	0.000128	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PIK3CG—hematologic cancer	2.99e-06	0.000125	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PIK3CD—hematologic cancer	2.99e-06	0.000125	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ALB—hematologic cancer	2.95e-06	0.000123	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PIK3R1—hematologic cancer	2.94e-06	0.000123	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PIK3CB—hematologic cancer	2.83e-06	0.000118	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PIK3R1—hematologic cancer	2.82e-06	0.000118	CbGpPWpGaD
Lacosamide—CA9—Metabolism—CREBBP—hematologic cancer	2.77e-06	0.000116	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PIK3CB—hematologic cancer	2.72e-06	0.000114	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PIK3CD—hematologic cancer	2.63e-06	0.00011	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PIK3CB—hematologic cancer	2.6e-06	0.000109	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ALB—hematologic cancer	2.59e-06	0.000108	CbGpPWpGaD
Lacosamide—CA14—Metabolism—PIK3CA—hematologic cancer	2.57e-06	0.000107	CbGpPWpGaD
Lacosamide—CA6—Metabolism—PIK3CA—hematologic cancer	2.5e-06	0.000105	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PIK3R1—hematologic cancer	2.48e-06	0.000104	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PTEN—hematologic cancer	2.45e-06	0.000102	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PTEN—hematologic cancer	2.35e-06	9.81e-05	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—PIK3CA—hematologic cancer	2.34e-06	9.77e-05	CbGpPWpGaD
Lacosamide—CA4—Metabolism—EP300—hematologic cancer	2.34e-06	9.76e-05	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PIK3CB—hematologic cancer	2.29e-06	9.57e-05	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PTEN—hematologic cancer	2.25e-06	9.41e-05	CbGpPWpGaD
Lacosamide—CA2—Metabolism—EP300—hematologic cancer	2.24e-06	9.36e-05	CbGpPWpGaD
Lacosamide—CA1—Metabolism—EP300—hematologic cancer	2.15e-06	8.97e-05	CbGpPWpGaD
Lacosamide—CA14—Metabolism—AKT1—hematologic cancer	2.1e-06	8.78e-05	CbGpPWpGaD
Lacosamide—CA6—Metabolism—AKT1—hematologic cancer	2.05e-06	8.55e-05	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PTEN—hematologic cancer	1.98e-06	8.27e-05	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—AKT1—hematologic cancer	1.91e-06	7.98e-05	CbGpPWpGaD
Lacosamide—CA9—Metabolism—EP300—hematologic cancer	1.89e-06	7.89e-05	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PIK3CA—hematologic cancer	1.73e-06	7.22e-05	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PIK3CA—hematologic cancer	1.66e-06	6.92e-05	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PIK3CA—hematologic cancer	1.59e-06	6.64e-05	CbGpPWpGaD
Lacosamide—CA4—Metabolism—AKT1—hematologic cancer	1.41e-06	5.9e-05	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PIK3CA—hematologic cancer	1.4e-06	5.83e-05	CbGpPWpGaD
Lacosamide—CA2—Metabolism—AKT1—hematologic cancer	1.35e-06	5.65e-05	CbGpPWpGaD
Lacosamide—CA1—Metabolism—AKT1—hematologic cancer	1.3e-06	5.42e-05	CbGpPWpGaD
Lacosamide—CA9—Metabolism—AKT1—hematologic cancer	1.14e-06	4.77e-05	CbGpPWpGaD
